| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | NFE2L3 HIVEP3 GFI1B ZNF492 HNF1B ZNF676 USF3 ZNF211 ZNF486 ZNF100 ZSCAN20 ESR1 ZNF846 ZNF735 ZNF483 ZNF431 ZNF91 ZNF229 ZNF726 | 4.82e-06 | 1412 | 84 | 19 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | NFE2L3 HIVEP3 GFI1B ZNF492 HNF1B ZNF676 USF3 ZNF211 ZNF486 ZNF100 ZSCAN20 ESR1 ZNF846 ZNF735 ZNF483 ZNF431 ZNF91 ZNF229 ZNF726 | 7.73e-06 | 1459 | 84 | 19 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | NFE2L3 HIVEP3 GFI1B ZNF492 HNF1B ZNF676 ZNF211 ZNF486 ZNF100 ZSCAN20 ESR1 ZNF735 ZNF483 ZNF431 ZNF91 ZNF229 ZNF726 | 1.37e-05 | 1244 | 84 | 17 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | NFE2L3 HIVEP3 GFI1B ZNF492 HNF1B ZNF676 ZNF211 ZNF486 ZNF100 ZSCAN20 ESR1 ZNF735 ZNF483 ZNF431 ZNF91 ZNF229 ZNF726 | 1.81e-05 | 1271 | 84 | 17 | GO:0000987 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | MEAF6 DCAF1 ZNF462 GFI1B HNF1B ESR1 EPC1 SHPRH SENP6 MLLT6 POGZ UBN2 ATAD2 ZNF726 EMSY | 1.27e-05 | 999 | 85 | 15 | GO:0071824 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF462 HIVEP3 GFI1B ZNF492 ZNF676 ZNF211 ZNF486 ZNF100 ZSCAN20 ZNF592 ZNF846 ZNF735 ZNF483 SCAPER ZNF431 POGZ ZNF91 ZNF229 ZNF726 | 1.15e-09 | 775 | 84 | 19 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF462 HIVEP3 GFI1B ZNF492 ZNF676 ZNF211 ZNF486 ZNF100 ZSCAN20 ZNF592 ZNF846 ZNF735 ZNF483 SCAPER ZNF431 POGZ ZNF91 ZNF229 ZNF726 | 1.20e-09 | 777 | 84 | 19 | PS00028 |
| Domain | zf-C2H2 | ZNF462 HIVEP3 GFI1B ZNF492 ZNF676 ZNF211 ZNF486 ZNF100 ZSCAN20 ZNF592 ZNF846 ZNF735 ZNF483 ZNF431 POGZ ZNF91 ZNF229 ZNF726 | 1.37e-09 | 693 | 84 | 18 | PF00096 |
| Domain | zf-C2H2_6 | GFI1B ZNF492 ZNF676 ZNF211 ZNF486 ZNF100 ZNF846 ZNF735 ZNF483 ZNF431 ZNF91 ZNF229 ZNF726 | 1.44e-09 | 314 | 84 | 13 | PF13912 |
| Domain | Znf_C2H2-like | ZNF462 HIVEP3 GFI1B ZNF492 ZNF676 ZNF211 ZNF486 ZNF100 ZSCAN20 ZNF592 ZNF846 ZNF735 ZNF483 SCAPER ZNF431 POGZ ZNF91 ZNF229 ZNF726 | 1.80e-09 | 796 | 84 | 19 | IPR015880 |
| Domain | Znf_C2H2 | ZNF462 HIVEP3 GFI1B ZNF492 ZNF676 ZNF211 ZNF486 ZNF100 ZSCAN20 ZNF592 ZNF846 ZNF735 ZNF483 SCAPER ZNF431 POGZ ZNF91 ZNF229 ZNF726 | 2.16e-09 | 805 | 84 | 19 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF462 HIVEP3 GFI1B ZNF492 ZNF676 ZNF211 ZNF486 ZNF100 ZSCAN20 ZNF592 ZNF846 ZNF735 ZNF483 SCAPER ZNF431 POGZ ZNF91 ZNF229 ZNF726 | 2.30e-09 | 808 | 84 | 19 | SM00355 |
| Domain | KRAB | ZNF492 ZNF676 ZNF211 ZNF486 ZNF100 ZSCAN20 ZNF846 ZNF735 ZNF483 ZNF431 ZNF91 ZNF229 ZNF726 | 9.99e-09 | 369 | 84 | 13 | SM00349 |
| Domain | KRAB | ZNF492 ZNF676 ZNF211 ZNF486 ZNF100 ZSCAN20 ZNF846 ZNF735 ZNF483 ZNF431 ZNF91 ZNF229 ZNF726 | 1.03e-08 | 370 | 84 | 13 | IPR001909 |
| Domain | - | ZNF462 HIVEP3 GFI1B ZNF492 ZNF676 ZNF211 ZNF486 ZNF100 ZSCAN20 ZNF846 ZNF735 ZNF483 ZNF431 ZNF91 ZNF229 ZNF726 | 4.99e-08 | 679 | 84 | 16 | 3.30.160.60 |
| Domain | KRAB | ZNF492 ZNF676 ZNF211 ZNF486 ZNF100 ZNF846 ZNF735 ZNF483 ZNF431 ZNF91 ZNF229 ZNF726 | 6.70e-08 | 358 | 84 | 12 | PS50805 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF462 HIVEP3 GFI1B ZNF492 ZNF676 ZNF211 ZNF486 ZNF100 ZSCAN20 ZNF846 ZNF735 ZNF483 ZNF431 ZNF91 ZNF229 ZNF726 | 6.74e-08 | 694 | 84 | 16 | IPR013087 |
| Domain | KRAB | ZNF492 ZNF211 ZNF486 ZNF100 ZNF846 ZNF735 ZNF483 ZNF431 ZNF91 ZNF229 ZNF726 | 5.86e-07 | 358 | 84 | 11 | PF01352 |
| Domain | START | 2.02e-03 | 15 | 84 | 2 | PF01852 | |
| Domain | START_lipid-bd_dom | 2.02e-03 | 15 | 84 | 2 | IPR002913 | |
| Domain | START | 2.02e-03 | 15 | 84 | 2 | PS50848 | |
| Domain | SEA | 4.36e-03 | 22 | 84 | 2 | PF01390 | |
| Domain | SEA | 4.76e-03 | 23 | 84 | 2 | PS50024 | |
| Domain | - | 4.76e-03 | 23 | 84 | 2 | 3.30.530.20 | |
| Domain | SEA_dom | 4.76e-03 | 23 | 84 | 2 | IPR000082 | |
| Domain | START-like_dom | 4.76e-03 | 23 | 84 | 2 | IPR023393 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 2.87e-05 | 16 | 54 | 3 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 3.48e-05 | 17 | 54 | 3 | M27412 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | MEAF6 HIVEP3 ZNF492 ZNF676 ZNF211 ZNF486 ZNF100 CAMK4 ESR1 ZNF735 EPC1 ZNF483 ZNF431 ATAD2 ZNF726 AFF4 | 3.99e-05 | 1387 | 54 | 16 | M734 |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 8.91e-05 | 23 | 54 | 3 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 1.30e-04 | 26 | 54 | 3 | M27483 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | STIM1 ZCCHC14 UBAP2 MYO9A STARD9 SEC24B COBL WNK1 FGD6 DMTN CRTC2 DOP1A FAM83B SHKBP1 | 2.55e-08 | 861 | 86 | 14 | 36931259 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | MEAF6 ZNF462 ZNF592 ZNF483 SHPRH SENP6 MLLT6 POGZ UBN2 ATAD2 EMSY AFF4 | 3.45e-08 | 608 | 86 | 12 | 36089195 |
| Pubmed | ZNF462 HIVEP3 ZCCHC14 GFI1B ZSCAN20 ZNF592 ESR1 SCAPER MLLT6 POGZ ZNF91 ATAD2 ZNF726 | 9.54e-08 | 808 | 86 | 13 | 20412781 | |
| Pubmed | Mucins: a biologically relevant glycan barrier in mucosal protection. | 6.04e-06 | 2 | 86 | 2 | 24821013 | |
| Pubmed | Differential Regulation of POC5 by ERα in Human Normal and Scoliotic Cells. | 6.04e-06 | 2 | 86 | 2 | 37239471 | |
| Pubmed | Membrane-bound mucin modular domains: from structure to function. | 6.04e-06 | 2 | 86 | 2 | 23178705 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 24103020 | ||
| Pubmed | 6.09e-06 | 181 | 86 | 6 | 37372979 | ||
| Pubmed | 7.86e-06 | 407 | 86 | 8 | 12693553 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 17998543 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 26770020 | ||
| Pubmed | CUL4B renders breast cancer cells tamoxifen-resistant via miR-32-5p/ER-α36 axis. | 1.81e-05 | 3 | 86 | 2 | 33638154 | |
| Pubmed | 1.94e-05 | 222 | 86 | 6 | 37071664 | ||
| Pubmed | 2.09e-05 | 225 | 86 | 6 | 12168954 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | MEAF6 CUL4B UBAP2 EML4 SENP6 MLLT6 POGZ UBN2 PLRG1 EMSY AFF4 | 2.34e-05 | 954 | 86 | 11 | 36373674 |
| Pubmed | 3.11e-05 | 493 | 86 | 8 | 15368895 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 28416635 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 21281489 | ||
| Pubmed | 4.22e-05 | 255 | 86 | 6 | 15324660 | ||
| Pubmed | MEAF6 ZNF462 HNF1B SINHCAF UBAP2 ZNF592 ESR1 SEC24B EPC1 MLLT6 POGZ UBN2 EMSY | 4.81e-05 | 1429 | 86 | 13 | 35140242 | |
| Pubmed | SIRT7 controls hepatic lipid metabolism by regulating the ubiquitin-proteasome pathway. | 6.01e-05 | 5 | 86 | 2 | 24703702 | |
| Pubmed | The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα. | 6.01e-05 | 5 | 86 | 2 | 28068668 | |
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 24719410 | ||
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 36066422 | ||
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 36056023 | ||
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 16684769 | ||
| Pubmed | Activin regulates estrogen receptor gene expression in the mouse ovary. | 9.01e-05 | 6 | 86 | 2 | 17951260 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 9.76e-05 | 430 | 86 | 7 | 35044719 | |
| Pubmed | Targeting USP2 regulation of VPRBP-mediated degradation of p53 and PD-L1 for cancer therapy. | 1.26e-04 | 7 | 86 | 2 | 37024504 | |
| Pubmed | 1.26e-04 | 7 | 86 | 2 | 23555860 | ||
| Pubmed | 1.28e-04 | 103 | 86 | 4 | 10819331 | ||
| Pubmed | The E3 ubiquitin ligase Cul4b promotes CD4+ T cell expansion by aiding the repair of damaged DNA. | 2.15e-04 | 9 | 86 | 2 | 33524014 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.41e-04 | 351 | 86 | 6 | 38297188 | |
| Pubmed | NEDD4L-mediated Merlin ubiquitination facilitates Hippo pathway activation. | 2.68e-04 | 10 | 86 | 2 | 33058421 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF462 HIVEP3 USF3 MYO9A SHPRH COBL UBN2 SHROOM2 KRCC1 AFF4 DOP1A SHKBP1 | 2.96e-04 | 1489 | 86 | 12 | 28611215 |
| Pubmed | 3.45e-04 | 529 | 86 | 7 | 14621295 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HIVEP3 ZCCHC14 ZNF592 TTLL4 RTTN COBL PCNX1 MLLT6 WNK1 C2CD2L | 4.01e-04 | 1105 | 86 | 10 | 35748872 |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 4.70e-04 | 259 | 86 | 5 | 30404004 | |
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 5.21e-04 | 265 | 86 | 5 | 19240061 | |
| Pubmed | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. | 5.23e-04 | 149 | 86 | 4 | 25231870 | |
| Pubmed | 6.21e-04 | 15 | 86 | 2 | 15885501 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 6.24e-04 | 420 | 86 | 6 | 28065597 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 6.46e-04 | 588 | 86 | 7 | 38580884 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 6.69e-04 | 774 | 86 | 8 | 15302935 | |
| Pubmed | 7.09e-04 | 16 | 86 | 2 | 8467795 | ||
| Pubmed | 7.09e-04 | 16 | 86 | 2 | 25807049 | ||
| Pubmed | 8.83e-04 | 298 | 86 | 5 | 30737378 | ||
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 9.01e-04 | 18 | 86 | 2 | 18834073 | |
| Pubmed | 9.02e-04 | 451 | 86 | 6 | 36168627 | ||
| Pubmed | 1.01e-03 | 19 | 86 | 2 | 15334068 | ||
| Pubmed | 1.01e-03 | 19 | 86 | 2 | 15647280 | ||
| Pubmed | 1.01e-03 | 19 | 86 | 2 | 17392787 | ||
| Pubmed | 1.12e-03 | 20 | 86 | 2 | 33355139 | ||
| Pubmed | ZNF592 ESR1 SEC24B UBN2 ATAD2 EMSY AFF4 FAM83B C2CD2L SHKBP1 NGDN | 1.15e-03 | 1497 | 86 | 11 | 31527615 | |
| Pubmed | 1.16e-03 | 83 | 86 | 3 | 20562864 | ||
| Pubmed | 1.23e-03 | 21 | 86 | 2 | 22467210 | ||
| Pubmed | 1.23e-03 | 21 | 86 | 2 | 25017104 | ||
| Pubmed | 1.23e-03 | 21 | 86 | 2 | 12601173 | ||
| Pubmed | 1.23e-03 | 21 | 86 | 2 | 27270040 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 1.25e-03 | 853 | 86 | 8 | 28718761 | |
| Pubmed | 1.32e-03 | 486 | 86 | 6 | 20936779 | ||
| Pubmed | 1.35e-03 | 22 | 86 | 2 | 12963728 | ||
| Pubmed | 1.35e-03 | 22 | 86 | 2 | 16024815 | ||
| Pubmed | 1.48e-03 | 23 | 86 | 2 | 31281901 | ||
| Pubmed | 1.48e-03 | 23 | 86 | 2 | 14966270 | ||
| Pubmed | Characterization of MRFAP1 turnover and interactions downstream of the NEDD8 pathway. | 1.48e-03 | 23 | 86 | 2 | 22038470 | |
| Pubmed | Hundreds of variants clustered in genomic loci and biological pathways affect human height. | 1.50e-03 | 198 | 86 | 4 | 20881960 | |
| Pubmed | ATRX proximal protein associations boast roles beyond histone deposition. | 1.52e-03 | 91 | 86 | 3 | 34780483 | |
| Pubmed | 1.58e-03 | 686 | 86 | 7 | 29987050 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.60e-03 | 341 | 86 | 5 | 32971831 | |
| Pubmed | 1.61e-03 | 24 | 86 | 2 | 17452356 | ||
| Pubmed | MEAF6 MFSD2A SINHCAF ZNF486 EPC1 SCAPER MUC12 ATAD2 WNK1 EMSY | 1.61e-03 | 1327 | 86 | 10 | 32694731 | |
| Pubmed | 1.61e-03 | 689 | 86 | 7 | 36543142 | ||
| Pubmed | 1.76e-03 | 1116 | 86 | 9 | 31753913 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 1.80e-03 | 208 | 86 | 4 | 33230847 | |
| Pubmed | 2.04e-03 | 101 | 86 | 3 | 9872452 | ||
| Pubmed | 2.10e-03 | 217 | 86 | 4 | 34048709 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 2.13e-03 | 724 | 86 | 7 | 36232890 | |
| Pubmed | 2.16e-03 | 103 | 86 | 3 | 32744500 | ||
| Pubmed | Ankyrin repeats of ANKRA2 recognize a PxLPxL motif on the 3M syndrome protein CCDC8. | 2.19e-03 | 28 | 86 | 2 | 25752541 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 2.20e-03 | 934 | 86 | 8 | 33916271 | |
| Pubmed | 2.29e-03 | 733 | 86 | 7 | 34672954 | ||
| Pubmed | 2.35e-03 | 29 | 86 | 2 | 14563677 | ||
| Interaction | H3-3A interactions | MEAF6 DCAF1 ZNF592 EML4 ESR1 ZNF483 SHPRH SENP6 MLLT6 POGZ UBN2 ATAD2 EMSY AFF4 | 2.80e-06 | 749 | 85 | 14 | int:H3-3A |
| Interaction | YWHAG interactions | STIM1 UBAP2 MYO9A STARD9 ESR1 SEC24B SHPRH PACS2 COBL WNK1 SHROOM2 FGD6 DMTN CRTC2 DOP1A FAM83B C2CD2L SHKBP1 | 3.62e-06 | 1248 | 85 | 18 | int:YWHAG |
| Interaction | YWHAH interactions | STIM1 ZCCHC14 UBAP2 MYO9A STARD9 ESR1 SEC24B PACS2 COBL WNK1 FGD6 DMTN CRTC2 DOP1A FAM83B SHKBP1 | 1.27e-05 | 1102 | 85 | 16 | int:YWHAH |
| Interaction | ZNF726 interactions | 1.55e-05 | 12 | 85 | 3 | int:ZNF726 | |
| Interaction | TLE3 interactions | 2.94e-05 | 376 | 85 | 9 | int:TLE3 | |
| Interaction | ZNF716 interactions | 5.26e-05 | 3 | 85 | 2 | int:ZNF716 | |
| Interaction | NUP43 interactions | DCAF1 STIM1 ZNF462 ZNF592 EPC1 SENP6 MLLT6 POGZ UBN2 ATAD2 EMSY | 6.22e-05 | 625 | 85 | 11 | int:NUP43 |
| Interaction | EGR2 interactions | 8.59e-05 | 171 | 85 | 6 | int:EGR2 | |
| Interaction | ASF1A interactions | 8.79e-05 | 249 | 85 | 7 | int:ASF1A | |
| Interaction | CRX interactions | 9.95e-05 | 254 | 85 | 7 | int:CRX | |
| Cytoband | 19p12 | 4.16e-10 | 90 | 86 | 7 | 19p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | 3.55e-09 | 122 | 86 | 7 | chr19p12 | |
| Cytoband | 6q24.3 | 1.89e-04 | 11 | 86 | 2 | 6q24.3 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF462 HIVEP3 GFI1B ZNF492 ZNF676 ZNF211 ZNF486 ZNF100 ZSCAN20 ZNF592 ZNF846 ZNF735 ZNF483 SCAPER ZNF431 ZNF91 ZNF229 ZNF726 | 4.96e-12 | 718 | 58 | 18 | 28 |
| GeneFamily | CD molecules|Mucins | 4.00e-05 | 21 | 58 | 3 | 648 | |
| GeneFamily | StAR related lipid transfer domain containing | 1.03e-03 | 15 | 58 | 2 | 759 | |
| Drug | estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A | 7.70e-06 | 192 | 85 | 7 | 5955_UP | |
| Drug | Acetopromazine maleate salt [3598-37-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 8.24e-06 | 194 | 85 | 7 | 6832_DN | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 8.52e-06 | 195 | 85 | 7 | 4117_DN | |
| Drug | Chloramphenicol [56-75-7]; Up 200; 12.4uM; PC3; HT_HG-U133A | 9.11e-06 | 197 | 85 | 7 | 1795_UP | |
| Drug | Methylatropine nitrate [52-88-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 9.73e-06 | 199 | 85 | 7 | 6495_DN | |
| Drug | Asiaticoside [16830-15-2]; Up 200; 4.2uM; MCF7; HT_HG-U133A | 8.37e-05 | 192 | 85 | 6 | 7004_UP | |
| Drug | Haloperidol [52-86-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 8.61e-05 | 193 | 85 | 6 | 5273_DN | |
| Drug | (-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 8.86e-05 | 194 | 85 | 6 | 7481_DN | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; PC3; HT_HG-U133A | 8.86e-05 | 194 | 85 | 6 | 3807_DN | |
| Drug | Androsterone [53-41-8]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 8.86e-05 | 194 | 85 | 6 | 5696_DN | |
| Drug | Carbamazepine [298-46-4]; Up 200; 17uM; PC3; HT_HG-U133A | 8.86e-05 | 194 | 85 | 6 | 1805_UP | |
| Drug | Trioxsalen [3902-71-4]; Down 200; 17.6uM; PC3; HT_HG-U133A | 9.11e-05 | 195 | 85 | 6 | 5736_DN | |
| Drug | Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; MCF7; HT_HG-U133A | 9.11e-05 | 195 | 85 | 6 | 6215_UP | |
| Drug | Megestrol acetate [595-33-5]; Up 200; 10.4uM; PC3; HT_HG-U133A | 9.37e-05 | 196 | 85 | 6 | 6667_UP | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | 9.37e-05 | 196 | 85 | 6 | 6708_DN | |
| Drug | Trifluridine [70-00-8]; Down 200; 13.6uM; PC3; HT_HG-U133A | 9.64e-05 | 197 | 85 | 6 | 5819_DN | |
| Drug | Zomepirac sodium salt [64092-48-4]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 9.64e-05 | 197 | 85 | 6 | 6815_DN | |
| Drug | 0225151-0000 [351320-15-5]; Down 200; 10uM; PC3; HT_HG-U133A | 9.64e-05 | 197 | 85 | 6 | 6389_DN | |
| Drug | Sulfanilamide [63-74-1]; Down 200; 23.2uM; PC3; HT_HG-U133A | 9.64e-05 | 197 | 85 | 6 | 4474_DN | |
| Drug | Clopamide [636-54-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 9.64e-05 | 197 | 85 | 6 | 5402_UP | |
| Drug | Droperidol [548-73-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 9.64e-05 | 197 | 85 | 6 | 2645_UP | |
| Drug | Articaine hydrochloride [23964-57-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 9.64e-05 | 197 | 85 | 6 | 6517_DN | |
| Drug | Thiorphan [76721-89-6]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 9.64e-05 | 197 | 85 | 6 | 6249_UP | |
| Drug | Cephalexin monohydrate [23325-78-2]; Down 200; 11uM; PC3; HT_HG-U133A | 9.91e-05 | 198 | 85 | 6 | 4654_DN | |
| Drug | Clozapine [5786-21-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.02e-04 | 199 | 85 | 6 | 5265_DN | |
| Drug | Finasteride [98319-26-7]; Down 200; 10.8uM; PC3; HT_HG-U133A | 1.02e-04 | 199 | 85 | 6 | 3744_DN | |
| Drug | Methimazole [60-56-0]; Down 200; 35uM; MCF7; HT_HG-U133A | 1.05e-04 | 200 | 85 | 6 | 4372_DN | |
| Drug | Ivermectin [70288-86-7]; Down 200; 4.6uM; PC3; HT_HG-U133A | 1.05e-04 | 200 | 85 | 6 | 5853_DN | |
| Drug | W-13, hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 1.05e-04 | 200 | 85 | 6 | 643_DN | |
| Disease | Fibroid Tumor | 1.14e-04 | 6 | 82 | 2 | C0023267 | |
| Disease | Uterine Fibroids | 1.59e-04 | 7 | 82 | 2 | C0042133 | |
| Disease | Intellectual Disability | 2.50e-04 | 447 | 82 | 7 | C3714756 | |
| Disease | gestational age | 6.04e-04 | 138 | 82 | 4 | EFO_0005112 | |
| Disease | peanut allergy measurement | 8.93e-04 | 16 | 82 | 2 | EFO_0007017 | |
| Disease | platelet component distribution width | 1.19e-03 | 755 | 82 | 8 | EFO_0007984 | |
| Disease | suicidal ideation, suicide behaviour | 2.02e-03 | 24 | 82 | 2 | EFO_0004320, EFO_0007623 | |
| Disease | unipolar depression, depressive symptom measurement | 2.37e-03 | 26 | 82 | 2 | EFO_0003761, EFO_0007006 | |
| Disease | PR interval | 2.58e-03 | 495 | 82 | 6 | EFO_0004462 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SHSALSHQVTAANSA | 731 | Q9H2F5 | |
| ADKVSSSASSSSHHE | 271 | P55198 | |
| TSASHFSGLQAHTTT | 56 | Q8N2A0 | |
| SHISANKLTTSVNSH | 1216 | Q8IZF6 | |
| SSQSSKHILSFHSAS | 1181 | Q8N7X0 | |
| ISGTTHTLHDSSVAS | 1241 | Q5JWR5 | |
| SSLELHNHSAASATG | 6 | Q6PL18 | |
| HNHSAASATGSLDLS | 11 | Q6PL18 | |
| AVSSLNSSHSRSHGN | 186 | Q9UHB7 | |
| TSGSSLSFHSTVINH | 361 | P08476 | |
| STFSHHKATSSITTG | 741 | Q8WXI7 | |
| NMGTASSAHVLHSTL | 4541 | Q8WXI7 | |
| GTRSAHTQSLTSVHS | 556 | Q8NA72 | |
| FHLDSGHKTSSRVNS | 241 | Q9Y4B6 | |
| HSQSETQLGSKSTSH | 1191 | P43146 | |
| ALTGMHTTSHSASTA | 451 | Q5SSG8 | |
| HTTSHSASTAVSEAK | 456 | Q5SSG8 | |
| SASSSHGSIQESHKA | 341 | Q16566 | |
| SQSSNLITHSRKHTG | 286 | Q5VTD9 | |
| HVASSSQSRKSSCSH | 1201 | Q5JUK3 | |
| KHSSSSNSQGSIHKS | 831 | Q5T0W9 | |
| SSSVIHRTASAHKSG | 546 | Q96RV3 | |
| ASVHTLSGHTNAVAT | 321 | O43660 | |
| SHLATAGSTSSHSLQ | 566 | P03372 | |
| SHNNTSVIKSNSSHS | 426 | Q9Y4A8 | |
| GLHHVNFSDSSKSRT | 816 | P09848 | |
| SHSENSVHTKSASVV | 31 | Q13614 | |
| LSHSSSQTEIGSIHS | 326 | Q86VP3 | |
| SSTVASQSANHTHGT | 231 | Q8NA29 | |
| ISVSHVGSTASKNSN | 91 | Q3MIT2 | |
| NSSSNHSALHSLVSS | 636 | Q8N264 | |
| DSTAKIHAVTHSSTG | 271 | Q5TID7 | |
| TSHSSSRDSHLSNGL | 491 | O14523 | |
| STSNLTHTMTHLGIS | 306 | Q53ET0 | |
| ISSHSSSGGSSHHAK | 106 | Q9P278 | |
| TSSLTSSIHGASNHC | 511 | O75128 | |
| ASSTSSGSHHSSHKK | 156 | Q9HAF1 | |
| SSDNSTSTHQASHKQ | 141 | Q9NPI7 | |
| SSHTAFTKHSEELGT | 906 | Q7Z589 | |
| SFTHNDSHLISTGGK | 841 | Q9HC35 | |
| STASFLSHHSTKANT | 881 | Q5M9N0 | |
| LKKSTSSDNSSSHHG | 246 | Q4AE62 | |
| FHTSLHQGTSKSSSL | 276 | Q08495 | |
| GAASSASHLHTSASQ | 136 | O95487 | |
| VKAHHTGSTASSEIT | 226 | Q9BY12 | |
| SVASVHHANGLAKSS | 166 | Q13620 | |
| HHANGLAKSSTTVSS | 171 | Q13620 | |
| TSSHKTTTSFHNSGN | 201 | Q3MIW9 | |
| SSHCQLAHSSSNTVS | 416 | A6NNC1 | |
| TSSSTISHHGNSAMV | 361 | P35680 | |
| SGSSSHAHVNSRISV | 336 | Q86VV8 | |
| NSHLSAASKGSNHSS | 501 | A2RUB1 | |
| SSLSSHTAGVTEKHS | 246 | Q5MJ70 | |
| NHSFTTDHGESTSKL | 181 | Q96L08 | |
| SSAATHNSHTGAAAS | 261 | O76100 | |
| AAHASVAGHLSTSTT | 56 | Q7Z3K3 | |
| SLHSASSNTSLSGHR | 631 | Q8TBC3 | |
| RSHTNSSAKHSEASV | 1651 | Q149N8 | |
| AKSNSSIDHLGSHSK | 191 | Q13796 | |
| IGVHFTSAVTHSSQK | 256 | Q96RA2 | |
| LAASATTLTHVGSTH | 1466 | Q9P2P6 | |
| QSLSHSHSEKATGTS | 21 | Q13586 | |
| SLGSSLSHSQSLSSH | 21 | Q14849 | |
| KRHNSDAHSTTSSAS | 116 | Q9NP50 | |
| NQSSTLSTHKFIHAG | 326 | Q8TF32 | |
| QSSTLTTHKITHAGE | 356 | Q8IYN0 | |
| SSHQSSLSAHAALSS | 706 | Q5T6F2 | |
| HVSSSSQAQIAASSH | 896 | Q6ZU65 | |
| TSGSTSAAFHHSLTQ | 1286 | Q6ZU65 | |
| GFSSVSTLNTHKAIH | 261 | Q8N7Q3 | |
| SFNHSSSGTTHKRIL | 221 | P0CB33 | |
| FTQSSGLSTHLRTHT | 431 | Q147U1 | |
| SFSKSSTLANHQRTH | 911 | P17040 | |
| SSQLHSLTHFSDISA | 266 | Q8NEJ9 | |
| FKTASSTADHSATQH | 836 | Q92610 | |
| NHKSPSSALSSVLHS | 1296 | Q6ZV73 | |
| AKSSLSQISSAATSH | 1081 | Q5T1R4 | |
| QSSSFSSHRKVHTGE | 436 | Q13398 | |
| NESLSSTHHTDGLSK | 896 | Q9GZR1 | |
| SSSATATKVHHGNKS | 306 | Q68DE3 | |
| SCSSHLSSHQKTHTG | 471 | Q9UJW7 | |
| SNSLENALHTSAHST | 66 | Q8WYQ9 | |
| SQSSTLTAHKIIHTG | 491 | A6NNF4 | |
| SQSSTLTTHKIIHTG | 291 | Q9P255 | |
| AFSNSSTLANHKITH | 666 | Q05481 | |
| LSSHSHHSSQKATPA | 2121 | Q96JM2 | |
| SHSSSLSKHQRIHTG | 561 | Q8TF39 | |
| HSSSGAQHASVSLET | 1666 | Q9H4A3 | |
| ASAHIALSTASSHDT | 281 | Q14679 | |
| TTSSNLTEHKTTHTG | 416 | Q96H40 | |
| TATKHFLDSSTNSGH | 206 | Q9UKN1 | |
| SGSGKTQSTNFLIHH | 241 | B2RTY4 |